Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Departamento de Medicina Legal, Bioética, Medicina do Trabalho e Medicina Física e Reabilitação, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
HGG Adv. 2024 Jan 11;5(1):100244. doi: 10.1016/j.xhgg.2023.100244. Epub 2023 Oct 4.
The germline TP53 p.R337H mutation is reported as the most common germline TP53 variant. It exists at a remarkably high frequency in the population of southeast Brazil as founder mutation in two distinct haplotypes with the most frequent co-segregating with the p.E134∗ variant of the XAF1 tumor suppressor and an increased cancer risk. Founder mutations demonstrate linkage disequilibrium with neighboring genetic polymorphic markers that can be used to identify the founder variant in different geographic regions and diverse populations. We report here a shared haplotype among Brazilian, Portuguese, and Spanish families and the existence of three additional distinct TP53 p.R337H alleles. Mitochondrial DNA sequencing and Y-STR profiling of Brazilian carriers of the founder TP53 p.R337H allele reveal an excess of Native American haplogroups in maternal lineages and exclusively European haplogroups in paternal lineages, consistent with communities established through male European settlers with extensive intermarriage with Indigenous women. The identification of founder and independent TP53 p.R337H alleles underlines the importance for considering the haplotype as a functional unit and the additive effects of constitutive polymorphisms and associated variants in modifier genes that can influence the cancer phenotype.
胚系 TP53 p.R337H 突变被报道为最常见的胚系 TP53 变体。它作为两个不同单倍型的创始突变,以极高的频率存在于巴西东南部的人群中,最常见的与 XAF1 肿瘤抑制因子的 p.E134∗变体共分离,并增加了癌症风险。创始突变与相邻遗传多态性标记物存在连锁不平衡,可用于在不同地理区域和不同人群中识别创始变体。我们在此报告了巴西、葡萄牙和西班牙家庭之间的共享单倍型,以及另外三个不同的 TP53 p.R337H 等位基因的存在。巴西携带创始 TP53 p.R337H 等位基因的个体的线粒体 DNA 测序和 Y-STR 分析揭示了母系中美洲原住民单倍型的过剩,以及父系中仅有的欧洲单倍型,这与通过与土著妇女广泛通婚的欧洲男性定居者建立的社区一致。创始和独立的 TP53 p.R337H 等位基因的鉴定强调了将单倍型视为功能单位的重要性,以及构成性多态性和相关变体在修饰基因中的附加效应,这些可以影响癌症表型。